Jesús San-Miguel

News Feed Opinion Blog Career Insight Dialogues Celebrities Oncolibrary
Positive Societies Drugs Stories History Cancer Center Near Me Cancer Types Immune Oncology Oncologist Near Me

Jesús San-Miguel
May 19, 2025, 09:53 | Science
Rahul Banerjee: Safety and Activity of Talquetamab in Patients with Relapsed or Refractory Multiple Myeloma
Rahul Banerjee, Assistant Professor at Fred Hutchinson Cancer Center at the University of Washington, posted…
Apr 13, 2025, 09:33 | Science
Myeloma Paper of the Day, April 13th, suggested by Robert Orlowski
Robert Orlowski, Florence Maude Thomas Cancer Research Professor at the University of Texas MD Anderson…
Apr 10, 2025, 15:20 | Drugs
Akhil Santhosh: Final Analysis of the ALCYONE Phase 3 Trial published in the Lancet Oncology
Akhil Santhosh, Medical Oncology Specialist at MVR Cancer Centre and Research Institute, shared a post…
Mar 18, 2025, 09:09 | Science
Myeloma Paper of the Day, March 18th, suggested by Robert Orlowski
Robert Orlowski, Florence Maude Thomas Cancer Research Professor at the University of Texas MD Anderson…
Nov 8, 2024, 13:40 | Insight
Myeloma Paper of the Day, November 8th, suggested by Robert Orlowski
Robert Orlowski shared a post on X: "Myeloma Paper of the Day: Results of a Phase 1b…
Oct 28, 2024, 06:36 | Positive
CARVYKTI® (ciltacabtagene autoleucel) was Awarded the Johnson Medal
Carvykti®: A Personalized Medicine Delivered Through a One-Time Infusion CARVYKTI® has been recognized with the Johnson…
Sep 24, 2024, 12:41 | Insight
Myeloma Paper of the Day, September 24th, suggested by Robert Orlowski
Robert Orlowski shared on X: “Myeloma Paper of the Day: Pre-clinical in vitro data suggest CD38/CD3xCD28…
All: 7 Posts: 1 - 100
Special Coverage